Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort Study.

Udeh-Momoh C, Price G, Ropacki MT, Ketter N, Andrews T, Arrighi HM, Brashear HR, Robb C, Bassil DT, Cohn M, Curry LK, Su B, Perera D, Giannakopoulou P, Car J, Ward HA, Perneczky R, Novak G, Middleton L.

J Prev Alzheimers Dis. 2019;6(4):256-266. doi: 10.14283/jpad.2019.31.

PMID:
31686098
2.

Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.

Harrison JE, Rentz DM, Brashear HR, Arrighi HM, Ropacki MT, Liu E.

J Prev Alzheimers Dis. 2018;5(4):236-244. doi: 10.14283/jpad.2018.31.

PMID:
30298182
3.

Dementia prevalence and incidence in a federation of European Electronic Health Record databases: The European Medical Informatics Framework resource.

Perera G, Pedersen L, Ansel D, Alexander M, Arrighi HM, Avillach P, Foskett N, Gini R, Gordon MF, Gungabissoon U, Mayer MA, Novak G, Rijnbeek P, Trifirò G, van der Lei J, Visser PJ, Stewart R.

Alzheimers Dement. 2018 Feb;14(2):130-139. doi: 10.1016/j.jalz.2017.06.2270. Epub 2017 Jul 21.

4.

Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients.

Ketter N, Brashear HR, Bogert J, Di J, Miaux Y, Gass A, Purcell DD, Barkhof F, Arrighi HM.

J Alzheimers Dis. 2017;57(2):557-573. doi: 10.3233/JAD-160216.

PMID:
28269765
5.

Validation of an MRI Rating Scale for Amyloid-Related Imaging Abnormalities.

Bechten A, Wattjes MP, Purcell DD, Aliaga ES, Daams M, Brashear HR, Arrighi HM, Barkhof F.

J Neuroimaging. 2017 May;27(3):318-325. doi: 10.1111/jon.12422. Epub 2017 Jan 19.

PMID:
28102639
6.

The Impact of Alzheimer's Disease on the Chinese Economy.

Keogh-Brown MR, Jensen HT, Arrighi HM, Smith RD.

EBioMedicine. 2015 Dec 22;4:184-90. doi: 10.1016/j.ebiom.2015.12.019. eCollection 2016 Feb.

7.

Age-Stratified Prevalence of Mild Cognitive Impairment and Dementia in European Populations: A Systematic Review.

Alexander M, Perera G, Ford L, Arrighi HM, Foskett N, Debove C, Novak G, Gordon MF.

J Alzheimers Dis. 2015;48(2):355-9. doi: 10.3233/JAD-150168. Review.

PMID:
26401999
8.

Incidence of stroke and seizure in Alzheimer's disease dementia.

Cook M, Baker N, Lanes S, Bullock R, Wentworth C, Arrighi HM.

Age Ageing. 2015 Jul;44(4):695-9. doi: 10.1093/ageing/afv061. Epub 2015 May 24.

PMID:
26008894
9.

Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis.

Arrighi HM, Barakos J, Barkhof F, Tampieri D, Jack C Jr, Melançon D, Morris K, Ketter N, Liu E, Brashear HR.

J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):106-12. doi: 10.1136/jnnp-2014-309493. Epub 2015 Feb 10.

10.

Understanding the relative importance of preserving functional abilities in Alzheimer's disease in the United States and Germany.

Hauber AB, Mohamed AF, Johnson FR, Cook M, Arrighi HM, Zhang J, Grundman M.

Qual Life Res. 2014 Aug;23(6):1813-21. doi: 10.1007/s11136-013-0620-5. Epub 2014 Jan 22.

PMID:
24448684
11.

Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature.

Ward A, Tardiff S, Dye C, Arrighi HM.

Dement Geriatr Cogn Dis Extra. 2013 Sep 28;3(1):320-32. doi: 10.1159/000354370. eCollection 2013.

12.

MR imaging features of amyloid-related imaging abnormalities.

Barakos J, Sperling R, Salloway S, Jack C, Gass A, Fiebach JB, Tampieri D, Melançon D, Miaux Y, Rippon G, Black R, Lu Y, Brashear HR, Arrighi HM, Morris KA, Grundman M.

AJNR Am J Neuroradiol. 2013 Oct;34(10):1958-65. doi: 10.3174/ajnr.A3500. Epub 2013 Apr 11.

13.

An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion.

Barkhof F, Daams M, Scheltens P, Brashear HR, Arrighi HM, Bechten A, Morris K, McGovern M, Wattjes MP.

AJNR Am J Neuroradiol. 2013 Aug;34(8):1550-5. doi: 10.3174/ajnr.A3475. Epub 2013 Feb 22.

14.

Longitudinal changes in functional disability in Alzheimer's disease patients.

Arrighi HM, Gélinas I, McLaughlin TP, Buchanan J, Gauthier S.

Int Psychogeriatr. 2013 Jun;25(6):929-37. doi: 10.1017/S1041610212002360. Epub 2013 Feb 13.

PMID:
23406898
15.

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.

Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Lieberburg I, Arrighi HM, Morris KA, Lu Y, Liu E, Gregg KM, Brashear HR, Kinney GG, Black R, Grundman M.

Lancet Neurol. 2012 Mar;11(3):241-9. doi: 10.1016/S1474-4422(12)70015-7. Epub 2012 Feb 3.

16.

Mild cognitive impairment: disparity of incidence and prevalence estimates.

Ward A, Arrighi HM, Michels S, Cedarbaum JM.

Alzheimers Dement. 2012 Jan;8(1):14-21. doi: 10.1016/j.jalz.2011.01.002. Review.

PMID:
22265588
17.

Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis.

Ward A, Crean S, Mercaldi CJ, Collins JM, Boyd D, Cook MN, Arrighi HM.

Neuroepidemiology. 2012;38(1):1-17. doi: 10.1159/000334607. Epub 2011 Dec 17. Review.

18.

Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis.

Crean S, Ward A, Mercaldi CJ, Collins JM, Cook MN, Baker NL, Arrighi HM.

Dement Geriatr Cogn Disord. 2011;31(1):20-30. doi: 10.1159/000321984. Epub 2010 Dec 1. Review.

19.

Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988-2007.

Baker NL, Cook MN, Arrighi HM, Bullock R.

Age Ageing. 2011 Jan;40(1):49-54. doi: 10.1093/ageing/afq146. Epub 2010 Nov 18.

PMID:
21087990
20.

Web-based application to project the burden of Alzheimer's disease.

Colantuoni E, Surplus G, Hackman A, Arrighi HM, Brookmeyer R.

Alzheimers Dement. 2010 Sep;6(5):425-8. doi: 10.1016/j.jalz.2010.01.014. Epub 2010 Aug 5.

PMID:
20691645
21.

Burden of Alzheimer's disease and association with negative health outcomes.

Malone DC, McLaughlin TP, Wahl PM, Leibman C, Arrighi HM, Cziraky MJ, Mucha LM.

Am J Manag Care. 2009 Aug;15(8):481-8.

22.

Lethality of Alzheimer disease and its impact on nursing home placement.

Arrighi HM, Neumann PJ, Lieberburg IM, Townsend RJ.

Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):90-5. doi: 10.1097/WAD.0b013e31819fe7d1.

PMID:
19568155
23.

Prevalence and impact of dementia-related functional limitations in the United States, 2001 to 2005.

Arrighi HM, McLaughlin T, Leibman C.

Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):72-8. doi: 10.1097/WAD.0b013e3181a1a87d.

PMID:
19568154
24.

Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.

Marehbian J, Arrighi HM, Hass S, Tian H, Sandborn WJ.

Am J Gastroenterol. 2009 Oct;104(10):2524-33. doi: 10.1038/ajg.2009.322. Epub 2009 Jun 16.

PMID:
19532125
25.

Worldwide variation in the doubling time of Alzheimer's disease incidence rates.

Ziegler-Graham K, Brookmeyer R, Johnson E, Arrighi HM.

Alzheimers Dement. 2008 Sep;4(5):316-23. doi: 10.1016/j.jalz.2008.05.2479.

PMID:
18790458
26.

Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease.

Hauber AB, Johnson FR, Fillit H, Mohamed AF, Leibman C, Arrighi HM, Grundman M, Townsend RJ.

Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):23-32. doi: 10.1097/WAD.0b013e318181e4c7.

PMID:
18725862
27.

Forecasting the global burden of Alzheimer's disease.

Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM.

Alzheimers Dement. 2007 Jul;3(3):186-91. doi: 10.1016/j.jalz.2007.04.381.

PMID:
19595937
28.

Correlates of osteoprotegerin levels in women and men.

Khosla S, Arrighi HM, Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Dunstan C, Riggs BL.

Osteoporos Int. 2002 May;13(5):394-9.

PMID:
12086350
29.

Does arsenic exposure increase the risk for circulatory disease?

Hertz-Picciotto I, Arrighi HM, Hu SW.

Am J Epidemiol. 2000 Jan 15;151(2):174-81.

PMID:
10645820
30.

The impact of asthma and asthma-like illness in Seattle school children.

Maier WC, Arrighi HM, Morray B, Llewllyn C, Redding GJ.

J Clin Epidemiol. 1998 Jul;51(7):557-68.

PMID:
9674662
31.

Indoor risk factors for asthma and wheezing among Seattle school children.

Maier WC, Arrighi HM, Morray B, Llewellyn C, Redding GJ.

Environ Health Perspect. 1997 Feb;105(2):208-14.

32.

A cost of illness study of allergic rhinitis in the United States.

Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C.

J Allergy Clin Immunol. 1997 Jan;99(1 Pt 1):22-7.

PMID:
9003207
33.
34.
35.
36.

US asthma mortality: 1941 to 1989.

Arrighi HM.

Ann Allergy Asthma Immunol. 1995 Apr;74(4):321-6.

PMID:
7719893
37.

The evolving concept of the healthy worker survivor effect.

Arrighi HM, Hertz-Picciotto I.

Epidemiology. 1994 Mar;5(2):189-96. Review.

PMID:
8172994
38.

Definitions, sources, magnitude, effect modifiers, and strategies of reduction of the healthy worker effect.

Arrighi HM, Hertz-Picciotto I.

J Occup Med. 1993 Sep;35(9):890-2. No abstract available.

PMID:
8229339
39.

Natural history of prostatism: urinary flow rates in a community-based study.

Girman CJ, Panser LA, Chute CG, Oesterling JE, Barrett DM, Chen CC, Arrighi HM, Guess HA, Lieber MM.

J Urol. 1993 Sep;150(3):887-92.

PMID:
7688433
40.

Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging.

Arrighi HM, Metter EJ, Guess HA, Fozzard JL.

Urology. 1991;38(1 Suppl):4-8.

PMID:
1714657
41.

Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia.

Guess HA, Arrighi HM, Metter EJ, Fozard JL.

Prostate. 1990;17(3):241-6.

PMID:
1700403
42.

Symptoms and signs of prostatism as risk factors for prostatectomy.

Arrighi HM, Guess HA, Metter EJ, Fozard JL.

Prostate. 1990;16(3):253-61.

PMID:
1691843
43.

Do the sisters of childbearing teenagers have increased rates of childbearing?

Friede A, Hogue CJ, Doyle LL, Hammerslough CR, Sniezek JE, Arrighi H.

Am J Public Health. 1986 Oct;76(10):1221-4.

Supplemental Content

Loading ...
Support Center